Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesis

Mander, Adrian P. ORCID: https://orcid.org/0000-0002-0742-9040, Wason, James M. S., Sweeting, Michael J. and Thompson, Simon G. 2012. Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesis. Pharmaceutical Statistics 11 (2) , pp. 91-96. 10.1002/pst.501

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Wiley
ISSN:	1539-1604
Last Modified:	04 Nov 2022 12:29
URI:	https://orca.cardiff.ac.uk/id/eprint/123279

Citation Data

Cited 26 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item